Too Much of a Good Thing

Mark Wijnen; N. Chantal Peltenburg; Dieuwertje Augustijn; Margreet A.E.M. Wagenmakers; Janneke G. Langendonk

doi:10.1056/nejmcps2510060

Too Much of a Good Thing

M Mark Wijnen (Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands) N N. Chantal Peltenburg (Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands) D Dieuwertje Augustijn (Laboratory of Clinical Genetics, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands) M Margreet A.E.M. Wagenmakers (Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands) J Janneke G. Langendonk (Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands)

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal New England Journal of Medicine

Volume / Issue Vol. 394, Issue 13

Published April 02, 2026

Pages 1326-1332

DOI 10.1056/nejmcps2510060

ISSN 0028-4793

Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (5)

M

Mark Wijnen

Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands

N

N. Chantal Peltenburg

Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands

D

Dieuwertje Augustijn

Laboratory of Clinical Genetics, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands

M

Margreet A.E.M. Wagenmakers

Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands

J

Janneke G. Langendonk

Department of Internal Medicine, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, the Netherlands

Too Much of a Good Thing

Article Details

Journal Info

Authors (5)

Related Articles from this Journal

Doctor’s Dirty Little Secret — The Cost of Silence

Obstructive Hypertrophic Cardiomyopathy

T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation

Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?

Precision Intensification in Metastatic Prostate Cancer